John McKearn has been promoted to CEO of Kalypsys, the San Diego-based company said last week.
McKearn joined the company in 2003 as chief scientific officer and became Kalypsys’ president in 2004. Prior to his employment with Kalypsys, he was senior vice president of research at Pharmacia. He has also held senior positions at G.D. Searle, the pharmaceutical subsidiary of Monsanto, Kalypsys said. McKearn holds a PhD in immunology from the University of Chicago and a bachelor’s degree from Northern Illinois University.